BioNexus Gene Lab (BGLC) EBT Margin (2018 - 2026)
BioNexus Gene Lab (BGLC) reported EBT Margin of 2379.72% for Q1 2026, down 235055.0% on a YoY basis from N/an in Q1 2025, and down 1011.08% sequentially from 214.18% in Q4 2025.
BioNexus Gene Lab (BGLC) EBT Margin (2018 - 2026) Analysis & Trends
BioNexus Gene Lab (BGLC) has 9 years of EBT Margin data on file, last reported at 2379.72% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 235055.0% year-over-year to 2379.72%; the trailing twelve-month figure through Mar 2026 stood at 54.7% (down 3166.0% YoY), and the FY2025 full-year result was 40.2%, down 2343.0% from the prior year.
- EBT Margin slipped to 2379.72% in Q1 2026, from 214.18% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 12.9% in Q2 2024 to a low of 2379.72% in Q1 2026.
- A 5-year average of 167.61% and a median of 10.72% in 2023 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin soared 4809 bps in 2024 and tumbled 235055 bps in 2026, its largest moves.
- Tracing BGLC's EBT Margin over 5 years: stood at 4.49% in 2022, then jumped by 349 bps to 11.16% in 2023, then tumbled by 250 bps to 16.72% in 2024, then slumped by 1181 bps to 214.18% in 2025, then slumped by 1011 bps to 2379.72% in 2026.
- Business Quant data shows BGLC's EBT Margin at 2379.72% in Q1 2026, 214.18% in Q4 2025, and 27.87% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn | 27.68% |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn | 12.00% |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn | 15.74% |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn | 27.85% |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn | 13.16% |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn | 1.90% |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn | 39.02% |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn | 7.62% |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn | 10.77% |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 | -2,379.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,379.72% |
| Dec 31, 2025 | -214.18% |
| Sep 30, 2025 | -27.87% |
| Jun 30, 2025 | -27.26% |
| Mar 31, 2025 | -29.17% |
| Dec 31, 2024 | -16.72% |
| Sep 30, 2024 | -51.09% |
| Jun 30, 2024 | 12.90% |
| Mar 31, 2024 | -3.51% |
| Dec 31, 2023 | 11.16% |
| Sep 30, 2023 | -99.18% |
| Jun 30, 2023 | -10.72% |
| Mar 31, 2023 | -2.23% |
| Dec 31, 2022 | -4.49% |
| Sep 30, 2022 | -2.61% |
| Jun 30, 2022 | -5.64% |
| Mar 31, 2022 | 1.04% |
| Dec 31, 2021 | 6.07% |
| Sep 30, 2021 | 10.36% |
| Jun 30, 2021 | 4.42% |